FMC - Willard is a medicare approved dialysis facility center in Willard, Ohio and it has 12 dialysis stations. It is located in Huron county at 209 Rae Court, Willard, OH, 44890. You can reach out to the office of FMC - Willard at (419) 935-0521. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Willard has the following ownership type - Profit. It was first certified by medicare in August, 2015. The medicare id for this facility is 362829 and it accepts patients under medicare ESRD program.
Dialysis Center Profile
| Name | FMC - Willard |
|---|
| Location | 209 Rae Court, Willard, Ohio |
|---|
| No. of Dialysis Stations | 12 |
|---|
| Medicare ID | 362829 |
|---|
| Managed By | Fresenius Medical Care |
|---|
| Ownership Type | Profit |
|---|
| Late Shifts | No |
|---|
NPI Associated with this Dialysis Facility:
Dialysis facilities may have several NPI numbers. We have found possible NPI numbers associated with FMC - Willard
from NPPES records by matching their name, address or phone number, so please use this information accordingly.
| NPI Number | 1306253364 |
| Match | Possible same name, address or phone number |
| Organization Name | Bio-medical Applications of Ohio, Inc. |
| Doing Business As | Fresenius Medical Care Willard |
| Address | 209 Rae Ct, Willard, Ohio 44890 |
| Phone Number | (419) 935-0521 |
Services Offered
- Hemodialysis
- Peritoneal Dialysis
- Home Hemodialysis Training
Patient Distribution
Dialysis Adequacy
For adult patients on hemodialysis, Kt/V should be at least 1.2 and for peritoneal dialysis at least 1.7; that means they are receiving the right amount of dialysis. For pediatric patients, Kt/V should be at least 1.2 on hemodialysis and 1.8 on peritoneal dialysis.
Higher percentages are better.
- Peritoneal Dialysis
| Adult patients getting regular peritoneal dialysis at the center | 9 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 58 |
Mineral and Bone Disorder
An important goal of dialysis is to maintain normal levels of various minerals
in the body, such as calcium. This shows the percentage of patients
treated at FMC - Willard with elevated calcium levels.
| Patients in the hypercalcemia summary | 13 |
| Hypercalcemia patient months | 95 |
| Patients in the serum phosphorus summary | 13 |
| Percentage of patients with serum phosphorus less than 3.5 mg/dL | 6 |
| Percentage of patients with serum phosphorus from 3.5 to 4.5 mg/dL | 29 |
| Percentage of patients with serum phosphorus from 4.6 to 5.5 mg/dL | 28 |
| Percentage of patients with serum phosphorus from 5.6 to 7 mg/dL | 25 |
| Percentage of patients with serum phosphorus greater than 7 mg/dL | 12 |
Vascular Access
The arteriovenous (AV) fistula is considered the best long-term vascular access for hemodialysis because it
allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access.
Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arteriovenous fistula and catheter summaries | 4 |
| Patient months included in arteriovenous fistula and catheter summaries | 40 |
Hospitalization Rate
The rate of hospitalization shows you whether patients who were being treated regularly at FMC - Willard were admitted to the
hospital more often (worse than expected), less often (better than expected), or about the same (as expected),
compared to similar patients treated at other centers.
| Standardized Hospitalization Ratio (SHR) Period | January, 2024 - December, 2024 |
| Patients in facility's Hospitalization Summary | 28 |
| Hospitalization Rate in facility | 83.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 210.3 |
| Hospitalization Rate: Lower Confidence Limit | 37.1 |
Readmission Rate
The rate of readmission shows you whether patients who were being treated regularly at FMC - Willard
were readmitted more often (worse than expected), less often (better than expected), or
about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standardized Readmission Ratio (SRR) Period | January, 2024 - December, 2024 |
| Readmission Rate in facility | 9.4 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 45.2 |
| Readmission Rate: Lower Confidence Limit | 0.2 |
Transfusion Summary
Patients with anemia require blood transfusions if their anemia is not managed well by their
dialysis center. This information shows whether FMC - Willard's rate of transfusions is better than expected,
as expected, or worse than expected, compared to other centers that treat similar patients.
| Standardized Transfusion Ratio (STrR) Period | January, 2024 - December, 2024 |
| Patients in facility's Transfusion Summary | 11 |
Survival Summary
The rate of mortality shows you whether patients who were being treated regularly at FMC - Willard lived longer than
expected (better than expected), did not live as long as expected (worse than expected), or lived as long as expected (as expected), compared
to similar patients treated at other facilities.
| Standardized Mortality Ratio (SMR) Period | January, 2021 - December, 2024 |
| Patients in facility's Survival Summary | 100 |
| Mortality Rate in facility | 22.2 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 38.5 |
| Mortality Rate: Lower Confidence Limit | 11.7 |